Reprogramming of somatic cells to induced pluripotent stem (iPS) cells can be achieved by the delivery of a combination of transcription factors, including Oct4, Sox2, Klf4, and c-Myc. Retroviral and lentiviral vectors are commonly used to express these four reprogramming factors separately and obtain reprogrammed iPS cells. Although efficient and reproducible, these approaches involve the time-consuming and labor-intensive production of retroviral or lentiviral particles together with a high risk of working with potentially harmful viruses overexpressing potent oncogenes, such as c-Myc. Here, we describe a simple method to produce bona fide iPS cells from human fibroblasts using poly--amino esters as the transfection reagent for the delivery of a single CAG-driven polycistronic plasmid expressing Oct4, Sox2, Klf4, c-Myc, and a GFP reporter gene (OSKMG). We demonstrate for the first time that poly--amino esters can be used to deliver a single polycistronic reprogramming vector into human fibroblasts, achieving significantly higher transfection efficiency than with conventional transfection reagents. After a protocol of serial transfections using poly--amino esters, we report a simple methodology to generate human iPS cells from human fibroblasts avoiding the use of viral vectors.In 2006, Yamanaka and Takahashi (1) showed for the first time that mouse embryonic fibroblast (MEFs) 3 can acquire a transcriptional profile and phenotype similar to an embryonic stem (ES) cell by ectopically expressing only four transcription factors. These so-called induced pluripotent stem (iPS) cells were generated by infecting MEFs with four retroviruses constitutively expressing Oct4, Sox2, Klf4, and c-myc (OSKM) (1). Since then several groups have confirmed these results and improved the reprogramming technique, generating iPS cells from mouse and human cells (2-7).iPS cells share many characteristic of ES cells. They form colonies with similar proliferation and morphological features, express a similar set of pluripotency markers, show comparable promoter methylation levels and telomerase activities and are able to differentiate both in vitro and in vivo into cell derivatives of the three germ layers. Hence, they represent a novel source of pluripotent stem cells with great potential for basic research, drug discovery, or autologous cell therapy.Retroviruses have been so far the most commonly used vectors to express the OSKM set of transcription factors into fibroblasts (1, 3, 5), neural stem cells, keratinocytes, or cord blood stem cells (8 -11) using sometimes different combinations of factors (7). Other viral gene transfer vectors such as lentiviruses have also allowed successful reprogramming (12, 13).The constitutive retroviral and lentiviral vectors commonly used for reprogramming allow efficient generation of iPS cells from mouse and human somatic cells. However, their permanent integration into the genome limits their use for eventual therapeutic applications due to the risk of both insertional mutagenesis and particul...